Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Melanoma × Dacarbazine × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 3 Melanoma 2 Uveal Melanoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplasms 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leiomyosarcoma 1 Advanced Melanoma 1

Interventions

Temozolomide 1 Paclitaxel 1 Dacarbazine 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07310784 2026-03-03

A Phase II Trial of LM103 in Advanced Melanoma

Suzhou BlueHorse Therapeutics Co., Ltd.

Phase 2 Recruiting

Advanced Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡